Endpoints News
Apnimed files for IPO Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
Mon T W Th F
13 July, 2026
Endpoints 11 - Reserve Your Spot
The most differentiated science stays out of public view. This September, the Endpoints newsroom reveals the 11 private companies worth watching, live at the State Room in Boston. See the list first, reserve your spot and save with the early bird rate.
news
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
ENDPOINTS NEWS
Apnimed files for IPO as FDA reviews its sleep apnea drug
ENDPOINTS NEWS
FDA returns to releasing pharma rejection letters with 14 new CRLs
ENDPOINTS NEWS
Endpoints webinars
Jul 30
1:00 pm ET
Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights
GUARDANT
Aug 19
1:00 pm ET
From pilots to production: AI across R&D, safety, regulatory, and clinical
IBM
Manufacturing Day 2026
A year into the tariff era, the biopharma industry has stopped bracing for impact — however manufacturing and supply chain leaders are still rewriting their plans on the fly. We’re bringing together the experts tracking what R&D logistics looks like today. Join us — find out what’s next.
ENDPOINTS PHARMA
FDA rejects Hengrui-Elevar liver cancer drug combo for third time
ENDPOINTS NEWS
CDER adds 100+ new employees in a quarter for first time since late 2024
ENDPOINTS NEWS
Peer Review
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
ENDPOINTS NEWS
in case you missed it
1.
German lawmakers pass cost-saving bill that drugmakers say will drive them out
ENDPOINTS NEWS
2.
News Briefing
Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injector
ENDPOINTS NEWS
3.
The data that led an AI biotech to pick up Novo's Parkinson's stem cell therapy
ENDPOINTS NEWS
4.
Maura Gillison, who transformed the treatment of mouth and throat cancers, dies at 61
WSJ
5.
AstraZeneca CEO: ‘Biology will catch up with me at some point’
Financial Times
6.
Think preprints are unreliable? Analysis of 70,000 studies might change your mind
NATURE
Reynald Castaneda
.

Elizabeth Cairns will be in Munich for the European Society of Cardiology Congress in late August. If you have any news to share, reach out here.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin